Contact information

Camilo Quevedo

MSc, PhD

Business Manager (LICR & CIO)

I am a business manager at the University of Oxford, supporting the Ludwig Institute for Cancer Research and The Centre for Immuno-Oncology. As a business manager, I provide operational, financial and strategic support to ensure our high standards and values are mantained, while we continue our cutting edge research in cancer across both institutions. During my career in administration, I have also provided management support to other NDM units such as The Centre for Human Genetics and The Jenner Institute.

Recent publications

Structure-based development of new RAS-effector inhibitors from a combination of active and inactive RAS-binding compounds

Cruz-Migoni A. et al, (2019), Proceedings of the National Academy of Sciences, 116, 2545 - 2550

bstract

(2018)

Small molecule inhibitors of RAS-effector protein interactions derived using an intracellular antibody fragment

Quevedo CE. et al, (2018), Nature Communications, 9

Correction: BRET-based RAS biosensors that show a novel small molecule is an inhibitor of RAS-effector protein-protein interactions

Bery N. et al, (2018), eLife, 7

BRET-based RAS biosensors that show a novel small molecule is an inhibitor of RAS-effector protein-protein interactions